Showing results (1-10 of 78) with videos related to
Sort By:
Pageof 8
Seizure|July 10, 2012
Frequently asked questions on epilepsy, pregnancy and lactation: a EURAP-NL reportAnca E Rapcencu, Dick Lindhout, Saskia BulkHuman Genetics|September 7, 2002
Favourable mutation test outcomes for individuals at risk for Huntington disease change the perspectives of first-degree relativesBenno Bonke, Aad Tibben, Dick Lindhout, et al.Neurology|October 28, 2009
Lamotrigine kinetics within the menstrual cycle, after menopause, and with oral contraceptivesIlse Wegner, Peter M Edelbroek, Saskia Bulk, et al.Epilepsy & Behavior : E&B|March 9, 2020
Well-being of mothers with epilepsy with school-aged childrenYfke Huber-Mollema, Frans J Oort, Dick Lindhout, et al.Epilepsy & Behavior : E&B|April 12, 2019
Maternal epilepsy and behavioral development of the child: Family factors do matterYfke Huber-Mollema, Frans J Oort, Dick Lindhout, et al.Epilepsia|June 6, 2019
Behavioral problems in children of mothers with epilepsy prenatally exposed to valproate, carbamazepine, lamotrigine, or levetiracetam monotherapyYfke Huber-Mollema, Frans J Oort, Dick Lindhout, et al.Epilepsy & Behavior : E&B|September 3, 2013
The impact of age on lamotrigine and oxcarbazepine kinetics: a historical cohort studyIlse Wegner, Abraham J Wilhelm, Josemir W Sander, et al.The Medical Journal of Australia|February 9, 2005
Genetic risk estimation by healthcare professionalsBenno Bonke, Aad Tibben, Dick Lindhout, et al.Epilepsia|January 7, 2004
Genetics of photosensitivity (photoparoxysmal response): a reviewUlrich Stephani, Ulrike Tauer, Bobby Koeleman, et al.Journal of Neurology|March 1, 2020
Neurocognition after prenatal levetiracetam, lamotrigine, carbamazepine or valproate exposureYfke Huber-Mollema, Loretta van Iterson, Frans J Oort, et al.Pageof 8